Eledon Pharmaceuticals Correlations

ELDN Stock  USD 3.55  0.06  1.66%   
The current 90-days correlation between Eledon Pharmaceuticals and Terns Pharmaceuticals is 0.5 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Eledon Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Eledon Pharmaceuticals and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.

Moving together with Eledon Stock

  0.61CDIOW Cardio DiagnosticsPairCorr
  0.73WMT WalmartPairCorr
  0.64BA BoeingPairCorr
  0.8HD Home DepotPairCorr
  0.82DIS Walt DisneyPairCorr
  0.62MSFT Microsoft Aggressive PushPairCorr

Moving against Eledon Stock

  0.4LUCD Lucid DiagnosticsPairCorr
  0.53XOM Exxon Mobil Corp Earnings Call This WeekPairCorr
  0.49JNJ Johnson Johnson Sell-off TrendPairCorr
  0.45CVX Chevron CorpPairCorr
  0.38T ATT Inc Sell-off TrendPairCorr
  0.31INTC Intel Sell-off TrendPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Eledon Stock performing well and Eledon Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eledon Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Eledon Pharmaceuticals Corporate Management

Marina EscuderoVP OperationsProfile
Gregory FlesherConsultantProfile
Bryan JDCorporate CounselProfile
John HerbergerVice OperationsProfile
Paul LittleChief OfficerProfile
David HovlandChief OfficerProfile